Prostate cancer remains the most commonly diagnosed cancer in men in the United States, with nearly 300,000 new cases expected by the end of 2024. According to the American Cancer Association, ...

Among US men with grade group 1 (GG1) prostate cancer, about 1 in 6 had intermediate- or high-risk disease, along with increased rates of adverse pathology and cancer-specific mortality. This finding ...

Grade group 1 prostate cancer assessment should include PSA, stage, and disease volume for accurate risk evaluation. Active surveillance is safe for most low-risk patients, but higher-risk features ...

Cancers are unpredictable and can be either containable or completely wreck your health. To make cancer treatments and research better, healthcare professionals use stages and characteristics, making ...

In a study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate ...

The prognosis of grade group 1 prostate cancer varies widely, with high-risk features increasing the possibility of adverse pathology, biochemical recurrence, and in some cases, death. Gleason grade ...

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural ...

Galen Prostate by IBEX achieved an AUC of 0.941 for distinguishing between low-grade and high-grade cancer. 50 DeepDX Prostate by Deep Bio achieved a high diagnostic concordance to the reference stand ...

A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

A PHASE 1/2 clinical trial has reported encouraging early outcomes for single-fraction stereotactic body radiotherapy (SBRT) ...

Radical prostatectomy is a standard curative approach for high-risk prostate cancer, yet accurately defining tumour margins during surgery remains a major challenge. Intraoperative assessment of ...